PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

40,991 stories, page 423 of 684

Advanced search
🌍Researchdoi.orgTier 1 · Research record

Pregnancy in CTD‐interstitial lung disease: Current evidence, clinical challenges, and a proposed management algorithm

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Evaluation of the reliability of current neonatal malnutrition indicators in diagnosis: An analysis of a retrospective cohort

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Lymphoplasmapheresis for Refractory Anti–N‐Methyl‐D‐Aspartate Receptor Encephalitis: A Case Report

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

The Efficacy of Adjunctive Platelet Concentrates in Combined Guided Tissue Regeneration and Bovine Bone Grafting for Intrabony Defects: A Systematic Review

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

High Cell Density Cultivation of HEK293 Cells Using a 2L Membrane‐Stirred Bioreactor

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Inventory Replenishment and Transshipment for Distributed Autologous Cell Therapy Manufacturing Networks

CrossrefOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Hansoh Pharmaceutical Group Company Limited Revenue Breakdown – DUS:3KY

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

India approves first dengue vaccine: Doctor explains its efficacy, side effects, and who should get it

Bhaskar EnglishOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The Biotech Scientist Now Running for Senate

MyNorthwest.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Legend Biotech Corp (LEGN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

TradingKeyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to book forward of Shanghai Xiao Fang Pharmaceutical Co., Ltd. Class A – SSE:603207

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

What Do MoonLake's Latest Week 40 HS Results Really Mean for Investors

Kavout | AIOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Honz Pharmaceutical Co., Ltd. Class A Revenue Breakdown – SZSE:300086

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

What is the latest on Capricor Therapeutics' Deramiocel and its FDA journey

Kavout | AIOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

A Win For RFK Or A Social Media Drug Trend? What The FDA’s Newest Vote Means

dailycaller.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Has Pfizer's Seagen Acquisition Reshaped the Oncology Landscape

Kavout | AIOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Why is MBX Biosciences' new CBO appointment so significant for investors

Kavout | AIOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Indrayani Biotech Ltd. Revenue Breakdown – BSE:INDRANIB

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBIT forward of Apeloa Pharmaceutical Co. Ltd. Class A – SZSE:000739

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

GC Biopharma targets $300m U.S. Alglio sales, expands Korea-led biotech push - CHOSUNBIZ

ChosunbizOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Health News Highlights: Legal, Infection, and Drug Developments

DevdiscourseOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Jiangsu Cowin Biotech Co., Ltd. Class A Revenue Breakdown – SSE:688426

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to earnings forward of Shanghai Xiao Fang Pharmaceutical Co., Ltd. Class A – SSE:603207

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to book forward of Hyundai Pharmaceutical Co., Ltd. – KRX:004310

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

PBF9 ETF Profile: Dividends, Returns (SWB:PBF9)

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Cai Lay Veterinary Pharmaceutical JSC Revenue Breakdown – HNX:MKV

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Teva Pharmaceutical Industries Limited Sponsored ADR Revenue Breakdown – BX:TEV

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Fermenta Biotech Ltd Revenue Breakdown – BSE:FERMENTA

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Purple Biotech Ltd. Sponsored ADR Revenue Breakdown – MUN:1YI0

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Has Ocugen's Recent Convertible Notes Offering Stabilized Its Financial Future

Kavout | AIOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Concord Biotech Ltd. Revenue Breakdown – NSE:CONCORDBIO

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

PBF9 ETF Profile: Dividends, Returns (MUN:PBF9)

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pune’s Moshi FDA lab remains non-operational a year after announcement

The Times of IndiaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

VRXA|Veraxa Biotech AG Ord Shs|Price:1.800|Chg%:-0.060

TradingKeyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

ETFs Investing in RTW Biotech Opportunities Ltd USD Stocks

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

200% tariff threat on US generic drug imports: What it means for India

The New Indian ExpressOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pharmaceutical team explores cooperation with Uzbekistan

The News PakistanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to earnings forward of CABIO Biotech (Wuhan) Co. Ltd. Class A – SSE:688089

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to revenue forward of Guizhou Bailing Group Pharmaceutical Co., Ltd. Class A – SZSE:002424

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Sichuan Huiyu Pharmaceutical Co. Ltd. Class A Revenue Breakdown – SSE:688553

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

CHINA RES PHARMACEUTICAL GROUP LTD. Revenue Breakdown – OTC:CRPGF

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBITDA forward of Shanghai Xiao Fang Pharmaceutical Co., Ltd. Class A – SSE:603207

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Sopan Pharmaceutical Ipo Analysis | Sopan Pharmaceutical Ipo | New Ipo Opening | Ipo Conor Mcgregor (wkIR5koJkM)

MshaleOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

NBR seeks 5yr pharma output data to verify VAT compliance

The Financial ExpressOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Sinovac Biotech Ltd (SVA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

TradingKeyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

US court rules abortion pill restrictions 'unlawful'

Medical XpressOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Recursion Pharmaceuticals Stock (RXRX) Opinions on Trading Ranges and Biotech Prospects

Quiver QuantitativeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Diabetes drug may help repair liver damage

24 News HDOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

ETFs Investing in West Pharmaceutical Services, Inc. Stocks

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Protect Pharmaceutical Corp Revenue Breakdown – OTC:PRTT

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Zhejiang Huahai Pharmaceutical Co., Ltd. Class A Revenue Breakdown – SSE:600521

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

CSPC Pharmaceutical Group Limited Revenue Breakdown – LS:548183

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

From Grant to Phase 3 Success: Advancing Rare Sarcoma Research – Conquer Cancer

OncodailyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

US generic drug tariff to have limited near-term impact on Indian firms: Report

India Tribune - ChicagoOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Approves New Over-the-Counter Tylenol With Naproxen For 12-Hour Pain Relief

parriva.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA panel narrowly backs unapproved peptide drugs favored by RFK Jr. and wellness influencers

WHEC.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Why controversial products claiming to help insomnia and migraines just got a big boost

The Washington PostOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Reyon Pharmaceutical Co., Ltd. Revenue Breakdown – KRX:102460

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Murata Stock And 2 Japanese Shares Investors Are Watching For Cash Flow Value

simplywall.stOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to sales forward of Shree Ganesh Biotech (India) Ltd. – BSE:SHREEGANES

TradingViewOriginal source